Interleukin-13 Antagonist

DBCAT005652Therapeutic category

A DrugBank category of 2 drugs. 2 of them are approved.

What you can answer from here — as of March 25, 2022

2DrugsEach linked to its full drug card

Listed above

1Drug targetEvery drug–target pair in the class, with bond type

30Marketed productsAcross the regions we cover, with dosage forms and routes

1Route of administrationHow the drugs in this class are given

Which targets do Interleukin-13 Antagonist share, and which companies have late-stage candidates in this class?

Create a free account or log in to explore the full data card.